Objective: To compare the accuracy of three newly proposed definitions of bronchopulmonary dysplasia (BPD) in predicting outcomes, and to investigate the impact of large airway vs. parenchymal vs. vascular BPD phenotypes on BPD outcomes.
Study Design: Retrospective chart review of 100 infants with severe BPD discharged from a Children's hospital between 2020-2021. Multivariable models evaluated the associations between BPD definitions and phenotypes with tracheostomy and death at 6 months and 1 year after NICU discharge. Secondary outcomes included need of respiratory support, use of pulmonary medications and need for long-term gastrostomy feeding.
Result: NRN and BPD collaborative criteria best predicted outcomes associated with tracheostomy and/or death (p < 0.001). Among the three BPD phenotypes, large airway disease was independently associated with death or tracheostomy (OR 10.5, 95% CI 1.6, 68.1). The combination of all three phenotypes was also associated with death or tracheostomy (OR 9.8, 95% CI 1.0, 93.5). Both NRN and BPD collaborative definitions showed association with the need for respiratory support, medication use and need for long-term gastrostomy tube feeding. Among the 29 infants for whom complete information was available, 18 (62%), 20 (69%), and 18 (62%) had parenchymal, central airway and pulmonary vascular phenotype, respectively.
Conclusion: Our results indicate that newer definitions of BPD may better predict severity of BPD and need for long-term invasive ventilation support compared to the 2001 NIH definition with BPD phenotypes impacting mortality and short-term outcomes. These data may be useful for counseling families and developing phenotype-based individualized treatment plans.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1055/a-2550-5306 | DOI Listing |
ACS Biomater Sci Eng
March 2025
Department of Biomedical Engineering, Tufts University, Medford, Massachusetts 02155-5801, United States.
Hypoxia in solid tumors, including head and neck cancer (HNC), contributes to treatment resistance, aggressive tumor phenotypes, and poorer clinical outcomes. Perfluorocarbon nanodroplets have emerged as promising drugs to alleviate tumor hypoxia. These versatile nanocarriers can also encapsulate and deliver various therapeutic agents, offering a multifunctional approach to cancer treatment.
View Article and Find Full Text PDFAm J Perinatol
March 2025
Pediatrics, Children's Mercy Hospitals and Clinics, Kansas City, United States.
Objective: To compare the accuracy of three newly proposed definitions of bronchopulmonary dysplasia (BPD) in predicting outcomes, and to investigate the impact of large airway vs. parenchymal vs. vascular BPD phenotypes on BPD outcomes.
View Article and Find Full Text PDFAutism Adulthood
December 2024
Department of Psychology, George Mason University, Fairfax, Virginia, USA.
Autism without intellectual disability is diagnosed later and with greater difficulty in girls/women relative to boys/men. For autistic girls and women, the journey to an autism diagnosis may include one or more misdiagnoses. Misdiagnosis with borderline personality disorder (BPD) or borderline traits may be particularly common, and characteristics often observed in autistic girls and women may contribute specifically to a risk of misdiagnosis with BPD.
View Article and Find Full Text PDFAntioxidants (Basel)
January 2025
Bio-X Institutes, Key Laboratory for The Genetics of Developmental and Neuropsychiatric Disorders, Shanghai Jiao Tong University, Shanghai 200030, China.
Many psychiatric disorders are associated with major cognitive deficits. However, it is uncertain whether these deficits develop as a result of psychiatric disorders and what shared risk factors might mediate this relationship. Here, we utilized the Mendelian randomization (MR) analysis to investigate the complex causal relationship between nine major psychiatric disorders and three cognitive phenotypes, while also examining the potential mediating role of oxidative stress as a shared biological underpinning.
View Article and Find Full Text PDFNature
February 2025
AbbVie, North Chicago, IL, USA.
Synthetic lethality exploits the genetic vulnerabilities of cancer cells to enable a targeted, precision approach to treat cancer. Over the past 15 years, synthetic lethal cancer target discovery approaches have led to clinical successes of PARP inhibitors and ushered several next-generation therapeutic targets such as WRN, USP1, PKMYT1, POLQ and PRMT5 into the clinic. Here we identify, in human cancer, a novel synthetic lethal interaction between the PELO-HBS1L and SKI complexes of the mRNA quality control pathway.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!